◆英語タイトル:Protokinetix Inc (PKTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7572
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
ProtoKinetix Inc (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company develops anti-aging glycopeptides used to protect cell lines including hela cells, neonatal fibroblasts, adult fibroblast, human neuronal stem cells, CD34+ cells and keratinocytes. It anti-aging glycopeptides also have commercial applications in the harvesting, storage, and transplantation of cells, tissues, and organs. ProtoKinetix offers products for health, stem cell and dermatology applications. It serves medical researchers in the areas of regenerative medicine and therapy for diseases. The company partners with universities and private research researchers to conduct its research activities. It performs tests in various outsourced laboratories to test neuronal retinal cells in living tissue for the treatment of macular degeneration. ProtoKinetix is headquartered in Marietta, Ohio, the US.
Protokinetix Inc (PKTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protokinetix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Protokinetix Inc, Medical Devices Deals, 2012 to YTD 2018 9
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Protokinetix Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
ProtoKinetix Acquires Certain Patents from University of Alberta 11
Partnerships 12
ProtoKinetix Enters into Research Agreement with University of British Columbia 12
ProtoKinetix and Proactive Immune Sciences Enter into Agreement 13
ProtoKinetix Enters into Research Agreement with University of British Columbia 14
ProtoKinetix Enters into Contract Research Agreement with ITR Labs 15
Equity Offering 16
Protokinetix Raises Additional USD0.4 Million in Private Placement of Shares 16
Protokinetix Raises USD0.2 Million in Private Placement of Shares 17
ProtoKinetix Raises USD0.2 Million in First Tranche of Private Placement of Shares 18
ProtoKinetix Raises USD0.2 Million in Private Placement of Units 19
ProtoKinetix Raises USD0.12 Million in Private Placement of Common Stock 20
Protokinetix Inc – Key Competitors 21
Protokinetix Inc – Key Employees 22
Protokinetix Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Legal and Regulatory 24
Jan 17, 2017: ProtoKinetix Announces Investigator Sponsored Clinical Trial Submitted to Health Canada for the use of AAGP in the Treatment of Type 1 Diabetes 24
Product News 25
Aug 10, 2018: ProtoKinetix enters into 3rd phase of Retinal Cell Replacement Therapy Testing at UBC 25
May 24, 2017: Protokinetix Completes First Year Of Trials On Retinal Replacement Therapy Using Aagp 26
Mar 09, 2017: Protokinetix Announces Start Of Phase 1 & Phase 2 Clinical Trials For The Use Of AAGP PKX-001 Treated Islet Cells In The Treatment Of Type 1 Diabetes 27
Jan 24, 2017: ProtoKinetix Announces Investigator Sponsored Human Clinical Trial Application Using AAGP Has Been Approved by Health Canada 28
Other Significant Developments 29
Nov 16, 2017: The Effects of ProtoKinetix’ Anti-Aging Glycopeptide (AAGP) on Immune Cell Banking and Functions Relevant to Immunotherapy 29
Oct 17, 2017: Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery 30
Feb 07, 2017: ProtoKinetix Updates Testing Progress on Neuronal Retinal Cells in Living Tissue for the Treatment of Macular Degeneration 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Tables
Protokinetix Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protokinetix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protokinetix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Protokinetix Inc, Medical Devices Deals, 2012 to YTD 2018 9
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ProtoKinetix Acquires Certain Patents from University of Alberta 11
ProtoKinetix Enters into Research Agreement with University of British Columbia 12
ProtoKinetix and Proactive Immune Sciences Enter into Agreement 13
ProtoKinetix Enters into Research Agreement with University of British Columbia 14
ProtoKinetix Enters into Contract Research Agreement with ITR Labs 15
Protokinetix Raises Additional USD0.4 Million in Private Placement of Shares 16
Protokinetix Raises USD0.2 Million in Private Placement of Shares 17
ProtoKinetix Raises USD0.2 Million in First Tranche of Private Placement of Shares 18
ProtoKinetix Raises USD0.2 Million in Private Placement of Units 19
ProtoKinetix Raises USD0.12 Million in Private Placement of Common Stock 20
Protokinetix Inc, Key Competitors 21
Protokinetix Inc, Key Employees 22
List of Figures
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Protokinetix Inc, Medical Devices Deals, 2012 to YTD 2018 9